These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1093656)

  • 1. Pharmacokinetics of trimethoprim-sulfamethoxazole in children.
    Wilfert CM; Gutman LT
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):73-6. PubMed ID: 1093656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole.
    Meares EM
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):22-5. PubMed ID: 236820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
    Harding GK; Ronald AR; Boutros P; Lank B
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic chemotherapy with low-dosage trimethoprim-sulfamethoxazole following acute urinary tract infections in children.
    Sher N
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):16-8. PubMed ID: 1093647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
    Kamme C; Melander A; Nilsson NI
    Scand J Infect Dis; 1983; 15(1):107-13. PubMed ID: 6342125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and clinical experiences of the combination sulfadiazine-trimethoprim in the short-term treatment of acute urinary tract infections.
    Seppänen J; Ylitalo P; Julkunen R; Räisänen S; Masar SE
    Ann Clin Res; 1980; (25):39-45. PubMed ID: 7377748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole in children: pharmacokinetics and clinical studies.
    Wilfert CM
    J Infect Dis; 1973 Nov; 128():Suppl:613-7 p. PubMed ID: 4585959
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
    Ronald AR; Harding CK; Mathias R; Wong CK; Muir P
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):13-6. PubMed ID: 1137829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic effects of trimethoprim-sulfamethoxazole in children with biliary atresia: a new dosing regimen.
    Lares-Asseff I; Villegas F; Pérez G; Toledo A; Camacho A; López DC
    Arch Med Res; 1996; 27(2):183-90. PubMed ID: 8696062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection.
    Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS
    Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infection prophylaxis in patients with hematological malignancies (I)--Successful prophylaxis of Pneumocystis carinii pneumonitis with sulfamethoxazole-trimethoprim].
    Moriuchi Y; Kamihira S; Satoh T; Yanagisako T; Miyazaki Y; Nagai K; Murata K; Tokunaga S; Maeda T; Atogami S
    Rinsho Ketsueki; 1990 Nov; 31(11):1818-22. PubMed ID: 2287067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of salmonella carriers with trimethoprim-sulfamethoxazole.
    Clementi KJ
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):28-32. PubMed ID: 1093650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim in pediatric urinary tract infection.
    Rajkumar S; Saxena Y; Rajagopal V; Sierra MF
    Child Nephrol Urol; 1988-1989; 9(1-2):77-81. PubMed ID: 3251626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of trimethoprim-sulfamethoxazole in gonococcal infections.
    Austin TW; Holmes KK
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):37-9. PubMed ID: 805648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The penetration of sulfadiazine, sulfamethoxazole and trimethoprim into the prostate gland, epididymis and testis in man.
    Seppänen J
    Ann Clin Res; 1980; (25):47-51. PubMed ID: 6990859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children.
    Lewin EB; Klein JO; Finland M
    J Infect Dis; 1973 Nov; 128():Suppl:618-21 p. PubMed ID: 4585960
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic parameters of children with urinary tract infection: effects of trimethoprim-sulfamethoxazole.
    Wolfish NM; Wassef N; Gonzalez H; Acharya C
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):76-9. PubMed ID: 1079471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethorpim-sulfamethoxazole in the treatment of chronic prostatitis.
    Dow D
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):26-7. PubMed ID: 1093649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP; Gronwall R; Castro L
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.